[Comparative effects of terbutaline sulphate and ipratropium bromide on the respiratory system (author's transl)]
- PMID: 6446008
[Comparative effects of terbutaline sulphate and ipratropium bromide on the respiratory system (author's transl)]
Abstract
Bronchodilator action of two pharmacologically different drugs have been compared. Ipratropium bromide (Sch 1000) is a synthetic atropine derivative and terbutaline sulphate is a beta-stimulating agent. Twelve asthmatic patients and eight patients with chronic bronquitis received terbutaline 0.50 mg. and ipratropium 0.04 mg by aerosol inhalation. Both drugs were given at random on a consecutive-day schedule. All patients were clinically stable before treatment (basal FEV/VC less than 60 percent). Total lung capacity (TLC) forced expiratory volume (FEV), SRaw, and V'/V curves before and at 15, 60, 120, and 240 minutes after the produce administration were registered. Presence of side-effects was also checked. An intensive bronchodilator action was observed either after inhalation of ipratropium bromide or terbutaline, but statistical studies showed no significant differences between both drugs in relation to intensity and duration of their actions. Sch 1000 caused similar bronchodilator effects in all cases; a more intense effect in patients with chronic bronchitis could not be noticed. Evaluation of V'/V curve, and especially its relation to a same pulmonary volume, pointed out that both drugs act upon small respiratory airways. Advance side-effects were not present.
Similar articles
-
Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols.Eur J Respir Dis. 1980 Oct;61(5):245-53. Eur J Respir Dis. 1980. PMID: 6451446 Clinical Trial.
-
Use of ipratropium bromide in obstructive lung disease.Clin Pharm. 1988 Sep;7(9):670-80. Clin Pharm. 1988. PMID: 2977109 Review.
-
Comparison of the bronchodilatory action and side-effects of ipratropium bromide and thiazinamium methyl sulphate: a long-term, double-blind, crossover trial in patients with chronic bronchitis.Pharmatherapeutica. 1982;3(3):180-7. Pharmatherapeutica. 1982. PMID: 6127719 Clinical Trial.
-
Combined treatment with ipratropium bromide and beta-2-adrenoceptor agonists in childhood asthma.Eur J Respir Dis. 1986 Apr;68(4):239-47. Eur J Respir Dis. 1986. PMID: 2874047 Clinical Trial.
-
Combined anticholinergic therapy in the management of acute asthma.Respirology. 1997;2 Suppl 1:S17-8. Respirology. 1997. PMID: 9400690 Review.
Cited by
-
Anticholinergic agents for chronic asthma in adults.Cochrane Database Syst Rev. 2004;2004(3):CD003269. doi: 10.1002/14651858.CD003269.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266477 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous